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Serum Amyloid A Facilitates Early Lesion Development in
Ldlr/ Mice
Paulette A. Krishack, PhD; Clarissa V. Bhanvadia, BA; John Lukens, BA; Timothy J. Sontag, PhD; Maria C. De Beer, PhD;
Godfrey S. Getz, MD, PhD; Catherine A. Reardon, PhD
Background-—Atherosclerosis is a chronic inflammatory disorder, and several studies have demonstrated a positive association
between plasma serum amyloid A (SAA) levels and cardiovascular disease risk. The aim of the study was to examine whether SAA
has a role in atherogenesis, the underlying basis of most cardiovascular disease.
Methods and Results-—Mice globally deficient in acute-phase isoforms Saa1 and Saa2 (Saa/) were crossed to Ldlr/ mice
(Saa/Ldlr/). Saa/Ldlr/ mice demonstrated a 31% reduction in lesional area in the ascending aorta but not in the aortic
root or innominate artery after consuming a high-fat, high-cholesterol Western-type diet for 6 weeks. The lesions were
predominantly macrophage foam cells. The phenotype was lost in more mature lesions in mice fed a Western-type diet for
12 weeks, suggesting that SAA is involved in early lesion development. The decreased atherosclerosis in the Saa/Ldlr/ mice
occurred despite increased levels of blood monocytes and was independent of plasma lipid levels. SAA is produced predominantly
by hepatocytes and macrophages. To determine which source of SAA may have a dominant role in lesion development, bone
marrow transplantation was performed. Ldlr/ mice that received bone marrow from Saa/Ldlr/ mice had slightly reduced
ascending aorta atherosclerosis compared with Saa/Ldlr/ mice receiving bone marrow from Ldlr/ mice, indicating that the
expression of SAA by macrophages may have an important influence on atherogenesis.
Conclusions-—The results indicate that SAA produced by macrophages promotes early lesion formation in the ascending aorta.
( J Am Heart Assoc. 2015;4:e001858 doi: 10.1161/JAHA.115.001858)
Key Words: atherosclerosis • macrophages • monocytes • serum amyloid A
S erum amyloid A (SAA) is a high-density lipoprotein(HDL)–associated apolipoprotein expressed primarily by
hepatocytes and macrophages. The Saa superfamily contains
4 members, with only isoforms 1 and 2 being acute-phase
reactants. Expression of SAA is induced by proinflammatory
cytokines, including interleukin (IL) 6, tumor necrosis factor
a, and IL-1b.1,2 Chronic expression of SAA is associated with
inflammatory diseases such as cardiovascular disease,
rheumatoid arthritis, and obesity.3–5 Several studies have
demonstrated a positive correlation between levels of acute-
phase proteins, such as C-reactive protein and SAA, and the
risk of development of cardiovascular disease and have
suggested that C-reactive protein and SAA may be biomar-
kers for cardiovascular disease. Plasma levels of SAA were
prognostic of 3-year coronary events in patients with
coronary artery disease.6,7 Expression of SAA was increased
at the site of plaque rupture in the coronary arteries of
patients with acute myocardial infarction compared with the
aorta, which was used as the internal negative control,
suggesting that SAA may contribute to plaque instability.8
Studies investigating a subgroup of patients with normal
levels of low-density lipoprotein (LDL) found that elevated
serum levels of C-reactive protein and SAA were risk factors
for patients with LDL levels <130 mg/dL.6 This suggests
that SAA may be a useful marker of cardiovascular disease,
particularly for patients who do not demonstrate high
cholesterol levels but who are still at risk for future
cardiovascular events.
Several studies have investigated the role of SAA in
atherosclerosis using various mouse models. Plasma levels of
SAA are increased in LDL receptor–deficient (Ldlr/) mice
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fed a high-fat diet (21% fat wt/wt) with or without added
cholesterol (0.15% wt/wt) for 5 and 10 weeks compared with
those fed a chow diet.3 Plasma levels of SAA after 5 weeks of
Western-type diet (WTD) feeding in Ldlr/ mice significantly
correlated with lesional area of the aortic root after 10 weeks
on a WTD, suggesting that systemic SAA levels may be
predictive of atherosclerosis development and may participate
in lesion development.3 SAA is present in atherosclerotic
lesions at all stages of development in both Ldlr/ and
apolipoprotein E–deficient (ApoE/) mice.3,9–11 The viral-
vector–mediated hepatic overexpression of human SAA1 in
ApoE/ mice has suggested that SAA may be proathero-
genic,11 although the absence of SAA in ApoE/ mice had no
effect on mature lesion formation,9 as did the transgenic
overexpression of SAA1 in adipocytes.12 SAA was also shown
to induce macrophage cholesterol uptake and expression of
the scavenger receptor lectin-like oxidized low-density protein
receptor 1 (LOX-1) in vitro via formyl peptide receptor, a
known receptor for SAA.13,14 It also induces proteoglycan and
glycosaminoglycan synthesis in vascular smooth muscle cells
in vitro and in the aorta in vivo by upregulating transforming
growth factor-b production.15 In addition, SAA is a chemo-
attractant for monocytes and neutrophils and induces the
expression of other chemokines such as monocyte chemo-
attractant protein-1 (MCP-1) and macrophage inflammatory
protein 1a.16,17 Incubation of human macrophages with
recombinant human SAA upregulates mature IL-1b and
cathepsin B production and activation of the NLRP3 inflam-
masome,18 which is required for the development of athero-
sclerosis in mice.19 Together, these in vitro and in vivo studies
suggest that SAA may be proatherogenic.
SAA is a secreted apolipoprotein produced primarily by
hepatocytes and macrophages and is found in the plasma
associated with HDL. Although it has been suggested that
SAA may have a proatherogenic role in lesion development,
the individual roles of SAA produced by macrophages and
hepatocytes in the development of atherosclerosis remain
unexplored.
The goal of this study was to examine the effect of the
absence of the acute-phase SAA isoforms SAA1 and SAA2 on
lesion formation in Ldlr/ mice, looking at both early and
late lesion development, and to further elucidate the role of
the individual cellular sources of SAA in atherogenesis. Ldlr/
 mice have several differences compared with ApoE/
mice, the most notable being their lipoprotein profiles, with
LDL being the major lipoprotein that accumulates in the
plasma in the Ldlr/ mouse model, similar to humans. In
addition, macrophages express apoE, which promotes cellular
cholesterol efflux. We showed that in the absence of SAA,
early lesion development is decreased in the ascending aorta
but not in the aortic root or innominate artery, independent of
effects on plasma lipids and despite an increase in blood
monocyte levels. We also demonstrated a novel role for
macrophage-derived SAA in atherogenesis.
Materials and Methods
Materials
All chemicals were purchased from Sigma-Aldrich unless
otherwise noted. DMEM and RPMI-1640 media were pur-
chased from Fisher Scientific.
All antibodies were purchased from eBioscience except as
follows. Anti-CD68 APC (FA-11) was purchased from Bioleg-
end. Goat anti-rabbit antibody (A-4914) was purchased from
Sigma-Aldrich (A-4914). Rat anti-mouse MOMA-2 (MCA519G)
was purchase from AbD Serotec. Rabbit anti-rat IgG H+L
chain AF594 was purchased from Invitrogen.
Primers for Real-Time Polymerase Chain Reaction
All primers were purchased from SA Biosciences, with the
exception of HPRT. The HPRT primer sequences were as
follows: forward, 50-ACC TCT CGA AGT GTT GGA TA-30, and
reverse, 50-CAA CAA CAA ACT TGT CTG GA-30.
Murine Studies
Mice globally deficient in both SAA1 and SAA2 (Saa/) on
the C57BL/6 background were generated as described.9,20
Ldlr/ mice, also on the C57BL/6 background, were
purchased from Jackson Laboratory (stock number 002207;
Bar Harbor, ME) and bred in-house. Saa/ mice were
crossed to Ldlr/ mice, with the genotype of Saa/Ldlr/
mice verified by genomic polymerase chain reaction (PCR) using
tail DNA. For all experiments, only female mice were used. Mice
were maintained on chow diet no. 2918 (4% fat, 0% cholesterol)
from Harlan Teklad until aged 8 weeks, when they were
switched to a high-fat, high cholesterol WTD (21% milk fat, 0.2%
cholesterol wt/wt; TD.88137 from Harlan Teklad) for 6 or
12 weeks. All mice were housed in a specific pathogen-free
facility and used in accordance with National Institutes of
Health guidelines and protocols approved by the institutional
animal care and use committee at the University of Chicago.
Quantification and Histology of Atherosclerosis
Atherosclerosis was quantified as previously described.21
Briefly, mice were anesthetized and perfused with PBS for
2 minutes, followed by 4% paraformaldehyde/5% sucrose in
PBS for 10 minutes. The heart, aortic arch, and its branching
arteries were dissected and soaked in 4% paraformaldehyde/
5% sucrose overnight at 4°C. The tissue was embedded in
optimum cutting temperature compound (Sakura Finetek) and
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stored at 80°C. Tissue was sectioned into 10-lm cryosec-
tions using a Leica cryostat (Leica Microsystems) and stained
with Gill’s hematoxylin (Fisher Scientific), oil red O, and fast
green (Sigma-Aldrich). For the innominate artery, lesion area
was quantitated in 4 cryosections located 150 to 450 lm
above the point where the innominate artery fuses with aortic
arch. For the ascending aorta, 3 cryosections were quanti-
tated from the first 300 lm of the apex of the lesser
curvature of the aortic arch. For the aortic root, 3 cryosec-
tions were quantitated beginning at the appearance of the
valve leaflets and the first coronary artery. For all 3 sites, each
of the cryosections quantitated was spaced by 100 lm and
the average lesion size was calculated. Adjacent aortic
sections were stained with hematoxylin and eosin using Gill’s
hematoxylin (Fisher Scientific) and eosin. For trichrome
staining, tissue was stained using Gomori’s trichrome
method.22 All images were acquired on a Leica DM IRB
microscope (Leica Microsystems) and analyzed using Open-
Lab 3.1.5 software (PerkinElmer).
Bone Marrow Transplantation Studies
Bone marrow was isolated from donors aged 8 to 12 weeks
by flushing the femurs and tibias with RPMI-1640 media
supplemented with 2% FCS, 1% penicillin–streptomycin, and
100 U/mL heparin. Red blood cells were lysed with ACK
buffer, the hematopoietic cells were resuspended in sterile
PBS, and 59106 cells were injected intravenously into
recipients aged 8 to 12 weeks. Recipient mice were lethally
irradiated using 2 doses of whole-body irradiation (500 rads
each) from a cesium 137 source, with the first dose 24 hours
prior to injection and the second on the morning of injection.
Recipient mice received acidified water containing sulfameth-
oxazole and trimethoprim 1 week prior to and 2 weeks after
injection. Recipient mice were fed a standard chow diet for
8 weeks to allow for reconstitution, after which they were fed a
WTD for 6 weeks. The heart and aorta were isolated and
analyzed, as described above.
Plasma Lipid and Lipoprotein Levels
Plasma levels of total cholesterol and triglycerides were
measured in mice fasted for 3 hours using enzymatic
colorimetric kits (Roche Diagnostics). Plasma lipoproteins
were separated by fast-performance liquid chromatography
using tandem Superose 6 columns (GE Healthcare), as
described previously.23
Flow Cytometry
Flow cytometry was used to quantify blood monocytes and
spleen macrophages. For all samples, cells were counted with
a hemocytometer, and Fc receptors were blocked using anti-
FccRII/III antibody 2.4G2 prior to adding the fluorescent-
tagged antibodies. For blood monocytes, mice were anesthe-
tized and bled through the retro-orbital sinus. Red blood cells
were lysed using red blood cell lysis buffer (eBioscience).
Monocytes were stained with CD45.2 PE (104), CD115-APC
(AFS98), and Ly6c PE-Cy7 (HK1.4). Total monocytes were
defined as CD45.2+CD115hi and separated into Ly6chi and
Ly6clo subsets. For splenocyte staining, spleens were man-
ually disrupted, processed into a single-cell suspension in
DMEM, supplemented with 5% FCS and 1% penicillin–strep-
tomycin, and filtered through a 70-lm filter. Red blood cells
were lysed with ACK lysis buffer. Splenocytes were stained
with CD45.2 PE (104) and F4/80 PerCP (BM8) and fixed with
1% paraformaldehyde for a minimum of 1 hour. Cells were
then permeabilized with 0.25% saponin and stained with
CD68 APC (FA-11). Macrophages were defined as
CD45.2+F4/80+CD68+. All percentages were normalized to
CD45.2. Dead cells were excluded from all samples using
fixable viability dye eFluor 450 (eBioscience). All flow
cytometry data were collected on the LSR II flow cytometer
(BD Biosciences) and analyzed using FlowJo software 10.0
(Tree Star).
Western Blot Analysis
Plasma from an individual mouse was loaded in each well of a
16% polyacrylamide gel. Proteins were separated using SDS-
PAGE, transferred to Immobilon at 4°C using 20% methanol
and 1x Tris-glycine. After blocking with 5% milk overnight at
4°C, the blots were probed with a rabbit anti-mouse SAA
antibody (1:3000 dilution), as described previously,24 for
1 hour at room temperature, followed by goat anti-rabbit
antibody (1:1000 dilution, A-4914) for 40 minutes at room
temperature. Peroxidase enhanced chemiluminescence Wes-
tern blotting substrate (Thermo Scientific Pierce) was used to
visualize bands. The Western blot signal was quantified using
FluorChem v2.0 Spot Denso software (ProteinSimple).
Immunofluorescent Staining of the Ascending
Aorta
Perfusion-fixed tissues were used for immunofluorescent
staining. Ascending aorta cryosections were soaked twice in
distilled water for 15 minutes to remove the optimum cutting
temperature compound, permeabilized with 0.15% Nonidet
P40 substitute for 15 minutes, washed in PBS, and blocked
with 10% FCS/PBS for 30 minutes at room temperature.
Sections were stained with a 1:100 dilution of rat anti-mouse
MOMA-2 (MCA519G) overnight at 4°C. Sections were then
stained with a 1:1000 dilution of rabbit anti-rat IgG H+L chain
AF594 for 1 hour and DAPI NucBlue Fixed Cell Stain
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(Invitrogen) for 7 minutes. Images were acquired on a Nikon
Eclipse Ti microscope (Nikon Instruments Inc) and analyzed
using ImageJ and OpenLab 3.1.5 software (PerkinElmer).
Quantitative Real-Time PCR
RNA was isolated from the aortic arch of Ldlr/ and
Saa/Ldlr/ mice fed a WTD for 6 weeks by TRIzol
(Invitrogen) extraction, according to the manufacturer’s
protocol. Next, 1.5 lg of RNA was used to make cDNA using
Superscript III (Invitrogen). Gene expression was quantified
using real-time PCR with 2 lL of cDNA diluted 1:16 and SYBR
green master mix (SA Biosciences, Qiagen). Gene expression
was normalized to housekeeping gene HPRT.
Statistical Analysis
Results are presented as mean+SEM. Normality of the data
was checked. When normally distributed, the data were
analyzed by unpaired Student t test or 1-way ANOVA (for
comparisons of ≥3) followed by Tukey’s multiple comparison
test. When not normally distributed, the data were analyzed
by Mann–Whitney U or Kruskal–Wallis test (for comparisons
of ≥3) followed by Dunn’s post hoc test. All data were
analyzed using GraphPad Prism 6 software for Macintosh
(GraphPad Software, Inc). Results were considered statisti-
cally significant with a P value of <0.05.
Results
Plasma SAA Levels Were Modestly Elevated in
Ldlr/ Mice Fed a WTD
Feeding Ldlr/ mice a high-fat, high-cholesterol WTD
increased plasma levels of SAA 4-fold after 6 and
12 weeks of diet compared with mice fed control chow
(Figure 1). This finding is in agreement with the studies of
Chait et al in Ldlr/ mice3 and De Beer et al in ApoE/
mice.9 This modest increase is in contrast to the 100- to
1000-fold increase observed in the acute-phase response,
and the fold increase is roughly comparable with the increase
in SAA in the plasma of patients with cardiovascular disease
compared with healthy controls.6,7
Early Atherosclerosis Decreased in the Ascending
Aorta of Saa/Ldlr/ Mice
To determine whether the absence of SAA would affect
atherosclerosis, cross-sectional analysis was used to examine
the ascending aorta, aortic root, and innominate artery in
Saa/Ldlr/ and Ldlr/ mice fed a WTD for 6 or
12 weeks. The absence of SAA resulted in a 31% reduction
in lesion size in the ascending aorta after 6 weeks of a WTD
but had no effect on lesion size in the innominate artery and
the aortic root (Figure 2A). Histological analysis of the
ascending aortic lesions in the mice fed a WTD for 6 weeks
(Figure 3) indicated that the lesions were almost completely
composed of foam cells staining positive for oil red O, with
little to no positive staining for collagen and/or connective
tissue, as indicated by trichrome staining. To determine
macrophage content, the ascending aorta from mice fed a
WTD for 6 weeks was stained for the macrophage marker
MOMA-2. In the absence of SAA, there was a reduction in
MOMA-2+ lesional area consistent with the reduced athero-
sclerosis, and no difference was found when normalized to
lesion area (percentage of MOMA-2+/lesional area) (Figure 4).
These data indicated that after 6 weeks of a WTD, lesions
were in early stages of development and consisted primarily
of macrophage foam cells.
To determine the effect of SAA on more mature lesions,
the mice were fed a WTD for 12 weeks; however, no
difference in lesion area was observed at any of the 3 arterial
sites (Figure 2B). The ascending aorta lesions after 12 weeks
of WTD were more complex, with an increase in collagen or
connective tissue and the presence of a fibrous cap and
A
B
Figure 1. Plasma levels of SAA were increased in Ldlr/ mice
fed a WTD. Ldlr/ mice were fed chow or a WTD for 6 or
12 weeks. SAA levels in the plasma were quantified by Western
blot. A, Western blot image showing SAA expression in plasma. All
samples were run on the same gel. B, Quantification of Western
blot. n=3 per group *P<0.01. SAA indicates serum amyloid A;
WTD, Western-type diet.
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necrotic core (Figure 5). When the extent of necrosis in the
ascending aorta after 12 weeks of a WTD in Saa/Ldlr/
mice was compared with Ldlr/ mice, no difference was
found in the necrotic area (53382369 versus
61221558 lm2, P<0.78) or percentage of necrotic area/
lesional area when quantified in hematoxylin and eosin–
stained sections (n=9 per strain). Taken together, these
results indicate that SAA participates in the development of
early atherosclerotic lesions in a site-specific manner.
Influence of SAA on Plasma Lipid Levels
To determine whether the moderate increase in SAA
expression in the WTD-fed mice influences plasma lipids,
cholesterol and triglyceride levels and lipoprotein classes in
the plasma were measured. As expected, because SAA
levels are barely detectable in chow-fed Ldlr/ mice, there
was no difference in plasma lipids in chow-fed Saa/Ldlr/
 and Ldlr/ mice (Figure 6A and 6B). In WTD-fed mice,
plasma cholesterol levels were higher in Saa/Ldlr/
mice after 12 weeks of diet (Figure 6A), with increased
levels of very low density lipoprotein (VLDL) and LDL
cholesterol but decreased levels of HDL cholesterol (Fig-
ure 6C). Although plasma triglyceride levels were higher in
the WTD-fed Saa/Ldlr/ mice compared with the Ldlr/
 mice, the difference was not significant (Figure 6B). These
data suggest that the influence of SAA on atherosclerosis is
not dependent on its influence on plasma lipids.
Gene Expression in the Aortic Arch
SAA may facilitate early lesion formation by inducing proin-
flammatory gene expression, particularly genes involved in
lesional monocyte recruitment and infiltration. Dong et al
demonstrated that SAA1 overexpression in the liver upregu-
lated expression of vascular adhesion molecule-1 (VCAM-1)
and the chemokine MCP-1 in the aortic root.11 SAA has also
been shown to induce MCP-1 in THP-1 cells and human
umbilical vein endothelial cells in vitro.25,26 To determine
whether the absence of SAA reduced lesional expression of
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Figure 2. The absence of SAA reduces atherosclerosis in the ascending aorta. Saa/Ldlr/ and Ldlr/ mice were fed a Western-type diet
for (A) 6 or (B) 12 weeks. Lesions in the ascending aorta, innominate artery, and aortic root were stained with oil red O, and cross-sectional area
was quantified. Each dot represents an individual mouse. n=9 to 13 for each group in (A) and 8 to 11 for each group in (B). *P<0.02. SAA
indicates serum amyloid A.
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VCAM-1 and MCP-1, quantitative real-time PCR was used to
quantify gene expression in the aortic arch from Saa/Ldlr/
 and Ldlr/ mice fed a WTD for 6 weeks. The aortic arch
included the ascending aorta but not the innominate artery or
aortic root. Although a modest reduction in VCAM-1 and MCP-
1 expression was found in the absence of SAA, the results
were not statistically significant (Figure 7).
SAA has also been shown to induce the proinflammatory
cytokine IL-23.27 IL-23 is known to induce production of
IL-17A by T-helper 17 cells. It has been shown that IL-17A can
promote atherosclerosis in certain contexts.28 In addition, IL-
6 is highly produced by M1 macrophages, inhibits M2
macrophage development, and is known to promote athero-
genesis.29,30 To determine whether the level of lesional mRNA
for these 2 proinflammatory cytokines was higher in the
presence rather than in the absence of SAA, real-time PCR
was used to quantify mRNA levels in the aortic arch of Ldlr/
and Saa/Ldlr/ mice fed a WTD for 6 weeks. No
difference was found in IL-17A and IL-6 mRNA levels
(Figure 7).
A
Ldlr-/- Saa-/-Ldlr-/-
B
C
Figure 3. Histological staining of the ascending aorta in Ldlr/ and Saa/Ldlr/ mice. Represen-
tative (A) oil red O, (B) H&E, and (C) trichrome staining of the ascending aorta after 6 weeks of a Western-
type diet. n=9 to 13 for oil red O staining and n=5 to 8 for H&E and trichrome staining. Scale bars: 100 lm.
H&E indicates hematoxylin and eosin.
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SAA From Bone Marrow–Derived Cells
Participated in the Regulation of Ascending Aorta
Atherosclerosis
SAA is a secreted protein primarily produced by hepatocytes
and macrophages; however, the roles that each of these
sources may play in atherosclerosis is unknown. To examine
this, we performed a 4-way bone marrow transplantation
study using Saa/Ldlr/ and Ldlr/ mice as donors and
recipients (Table). Consistent with the studies with the global
knockout mice, ascending aorta lesion size was lower in
Saa/Ldlr/?Saa/Ldlr/ chimeric mice that did not
produce any SAA compared with Ldlr/?Ldlr/ chimeric
mice (Figure 8A). Chimeric mice that did not express SAA in
macrophages (Saa/Ldlr/?Saa/Ldlr/ and Saa/
Ldlr/?Ldlr/) had modestly lower atherosclerotic
lesions compared with mice expressing SAA in macrophages
(Ldlr/?Ldlr/ and Ldlr/?Saa/Ldlr/). In con-
trast, mice expressing SAA in macrophages (ie, recipients
of Ldlr/ bone marrow) had a comparable amount of
Ldlr-/-
Saa-/- Ldlr-/-
Figure 4. MOMA-2 staining of the ascending aorta in Saa/Ldlr/ and Ldlr/ mice fed a Western-type diet
for 6 weeks. Shown are representative images with the magnified images of the region outlined in white shown on
the right. DAPI is shown in blue and MOMA-2 is shown in red. Scale bars: 100 lm. MOMA-2+ area was
quantitated and expressed as total area (right) or as percentage of total lesion area (left). n=7 to 8 per group.
*P<0.005.
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atherosclerosis whether or not SAA was produced by
hepatocytes. Consistent with the reduced atherosclerosis in
chimeric mice lacking SAA expression in macrophages, there
was a decrease in MOMA-2+ lesional area, but no differences
were found in the percentage of MOMA-2+/lesional area
(Figure 8B), indicating that neither source of SAA affects the
relative macrophage content of the ascending aorta lesions.
The results from the bone marrow transplantation studies
indicated that SAA produced by macrophages had a greater
role in enhancing early ascending aorta lesion formation in
Ldlr/ mice than SAA produced by hepatocytes.
A Western blot for SAA was performed on plasma from the
bone marrow recipients to assess whether macrophages
contributed to plasma SAA levels. SAA was detected in the
plasma of the recipient mice when SAA was expressed in
hepatocytes (Ldlr/?Ldlr/ and Saa/Ldlr/?Ldlr/)
Saa-/-Ldlr-/-Ldlr-/-
A
B
C
Figure 5. Histological staining of the ascending aorta in Ldlr/ and Saa/Ldlr/ mice after 12 weeks
of a WTD. Representative (A) oil red O, (B) H&E, and (C) trichrome staining of the ascending aorta after
12 weeks of WTD. n=8 to 11 per group for oil red O staining and n=5 per group for H&E and trichrome
staining. Scale bars: 100 lm. H&E indicates hematoxylin and eosin; WTD, Western-type diet.
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but not when SAA was expressed only in bone marrow–
derived cells (Ldlr/?Saa/Ldlr/) (Figure 8C). These
results indicated that hepatocytes produced the majority of
SAA found in the plasma of Ldlr/ mice fed a WTD, with
macrophages contributing little if any plasma SAA. Conse-
quently, the SAA produced locally by bone marrow–derived
cells may promote the development of atherosclerosis in the
ascending aorta.
Atherosclerosis was Reduced in the Ascending
Aorta Despite Increased Levels of Blood
Monocytes
Monocytosis in both blood and spleen is associated with an
increased risk for the development of atherosclerosis.31–33 A
possible explanation for the decreased atherosclerosis in the
WTD-fed Saa/Ldlr/ mice is that they may have lower
blood levels of monocytes. Blood monocytes were quantified
using flow cytometry in Saa/Ldlr/ and Ldlr/ mice fed
chow and a WTD for 6 weeks. In the chow-fed animals, there
was no difference in blood monocytes (CD45+CD115+) in the
presence and absence of SAA expression (Figure 9B). Con-
trary to what was expected, in the absence of SAA in WTD-fed
mice, the percentage of total monocytes was increased after
6 weeks on a WTD (Figure 9C). Further analysis indicated that
it was primarily the Ly6clo monocyte subset that was
elevated. These data are significant because we observed a
reduction in atherosclerosis at this time point despite an
increase in total blood monocytes, which is often positively
associated with atherosclerosis. We did not observe a
significant difference in blood monocytes after 12 weeks of
WTD, although there was a trend toward increased levels in
Saa/Ldlr/ mice (Figure 9C).
The reason for the increased blood monocytes in the
absence of SAA in the mice fed a WTD for 6 weeks is
unclear. We did not observe a significant difference in
splenic monocyte (CD45+F4/80CD11b+Ly6c high or low)
levels—a potential reservoir of blood monocytes and tissue
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macrophages—after 6 or 12 weeks on a WTD (data not
shown). In addition, we did not observe a difference in blood
monocyte proliferation, as determined by cell cycle analysis
via flow cytometry, indicating that the absence of SAA does
not promote monocytosis by increasing proliferation (data
not shown).
To determine which source of SAA might be influencing
blood monocyte levels, blood monocytes were quantified
using flow cytometry in the bone marrow recipients after
6 weeks of a WTD. Similar to the nonchimeric mice, the
percentage of total monocytes was increased only in recip-
ients not expressing SAA in hepatocytes or macrophages
(Saa/ Ldlr/?Saa/ Ldlr/ mice) and was primarily
due to a higher level of Ly6clo monocytes (Figure 9D).
Interestingly, the data suggest that the difference in Ly6clo
monocytes is due to both hematopoietic and nonhematopoi-
etic factors because recipients that expressed either source
of SAA equally prevented an increase in both total and Ly6clo
monocytes compared with recipients totally deficient in SAA.
Further experiments are required to determine how the
presence and absence of SAA modulates monocyte homeo-
stasis in Ldlr/ mice fed a WTD. This issue is under current
investigation.
To determine whether the difference in the levels of Ly6clo
monocytes influenced the development of atherosclerosis
after 6 weeks of WTD feeding, Pearson’s correlation test was
performed on both data sets. No correlation was found in
either case (Figure 9E), suggesting that the influence of SAA
on peripheral blood Ly6clo monocyte levels was independent
of its influence on atherogenesis.
Macrophages Were Reduced in the Spleen and
Peritoneal Cavity Despite the Elevation of Blood
Monocytes
The spleen has been shown to serve as a reservoir for
monocytes and macrophages on consumption of a high-fat,
high-cholesterol diet that can be recruited to aortic lesions
contribute to the growth of atherosclerotic lesions.32,34 As
mentioned above, there was no difference in the number of
monocytes in the spleen as a function of the presence or
absence of SAA. We used flow cytometry to determine
whether SAA influenced the amount of macrophages
(CD45.2+F4/80+CD68+ cells) in the spleen and peritoneal
fluid of mice fed a WTD for 6 weeks. Spleen and resident
peritoneal macrophages were increased in the presence of
SAA (Figure 10A through 10C). To determine whether SAA
expressed by macrophages and/or hepatocytes promoted an
increase in splenic macrophages, we also quantified splenic
macrophages in the bone marrow recipients. Recipients that
did not express SAA in macrophages (Saa/Ldlr/?Saa/
Ldlr/ and Saa/Ldlr/?Ldlr/) demonstrated
lower levels of splenic macrophages compared with recipients
that expressed SAA in macrophages (Figure 10D). These
results indicate that SAA produced by macrophages may
increase the amount of macrophages in the spleen in WTD-fed
mice.
Table. Site of SAA Expression in Bone Marrow Chimeric Mice
Donor Recipient Site of SAA Expression
Ldlr/ Ldlr/ Hepatocytes and macrophages
Saa/Ldlr/ Saa/Ldlr/ None
Ldlr/ Saa/Ldlr/ Macrophages
Saa/Ldlr/ Ldlr/ Hepatocytes
SAA indicates serum amyloid A.
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Figure 7. Expression of VCAM-1, MCP-1, IL-6, and IL-17A in the aortic arch of Ldlr/ and Saa/Ldlr/ mice fed a WTD for 6 weeks. RNA
was isolated from the aortic arch using TRIzol extraction. cDNA was amplified and real-time PCR was performed to quantify expression level of
VCAM-1, MCP-1, IL-6, and IL-17A. Expression of each gene was normalized to HPRT. For each group, n=4 to 5 mice. IL indicates interleukin;
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Discussion
This study is the first report of an examination of the effect of
the absence of the acute-phase protein SAA on atherogenesis
in the Ldlr/ background. We identified 3 novel findings
related to SAA and atherogenesis and monocyte biology. First,
we found that SAA deficiency attenuated atherogenesis in the
ascending aorta during early lesion development and did not
influence mature lesion formation. This is a site-selective
response because these differences were found only in the
ascending aorta after 6 weeks of WTD. Second, we showed
that this attenuation appeared to be attributable to the
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Figure 8. SAA produced by macrophages may promote atherosclerosis and increase the amount of
lesional macrophages. Bone marrow transfer recipients were fed a Western-type diet for 6 weeks. A, The
ascending aorta was stained with oil red O, and cross-sectional area was quantified. Each dot represents an
individual mouse. n=7 to 10 for all groups. B, MOMA-2+ lesional area was quantified in the ascending aorta
in chimeric Ldlr/ and Saa/Ldlr/ recipient mice. n= 4 to 5 per group. C, Plasma SAA levels in
chimeric Ldlr/ and Saa/Ldlr/ recipient mice were analyzed by Western blot. Data are expressed as
relative light units per microgram of plasma. n=3 per group. *P<0.05; **P<0.01. L indicates Ldlr/; SAA,
serum amyloid A; SL, Saa/Ldlr/.
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absence of SAA production by macrophages, as discerned
from bone marrow transplantation experiments. Third, we
demonstrated that despite there being less atherosclerosis in
the absence of SAA, there were higher levels of total blood
monocytes.
The absence of SAA in Ldlr/ mice resulted in a reduction
in early lesion formation in the ascending aorta but not in the
innominate artery or aortic root after 6 weeks of a WTD.
Histological staining of the ascending aorta indicated that
lesions after 6 weeks of a WTD were early in development and
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consisted primarily of macrophage foam cells, with very little
connective tissue and/or collagen content. After 12 weeks of
a WTD, lesions in both Saa/Ldlr/ and Ldlr/ mice were
similar in size and more mature in composition. The reason for
the site-specific effect of SAA is not clear, but the lack of an
effect on aortic root lesions may be related to the fact that
this site is the first in mice to develop atherosclerosis, and
thus the lesions at this site are more mature even in the mice
fed a WTD for 6 weeks. In contrast, the lesions in the
innominate artery were very small, yet there was no effect of
SAA deficiency. SAA does not appear to influence cholesterol
loading of the foam cells because no difference was found in
cholesterol uptake by peritoneal macrophages from the 2
strains of mice in vitro with acetylated LDL or in vivo in WTD-
fed mice or in the expression LOX-1 in the ascending aorta
(data not shown). Our results suggest that SAA may influence
lesion formation by affecting processes involved in early
lesion formation, such as increased expression of adhesion
molecules and chemokines involved in leukocyte and mono-
cyte infiltration, although differences in differentiation of
monocytes into macrophages or their retention in the aortic
tissue30,35–38 may also have a role. Previous in vitro and
in vivo studies have found that increased levels of SAA
regulate expression of adhesion molecules such as VCAM-1,
CD62L (L-selectin), and CD11b and chemokines such as MCP-
1 in endothelial cells, leukocytes, and aortic root lesions.11,16
We observed a trend toward higher expression of VCAM-1 and
MCP-1 in the aortic arch in mice expressing SAA. Ly6chi
monocytes are also known to express CC chemokine receptor
2 (CCR2), the chemokine receptor for MCP-1. Ly6chi mono-
cytes are also known to preferentially express formy peptide
receptor 2 (FPR2), a key signaling receptor for SAA. Conse-
quently, in the presence of SAA, Ly6chi monocytes might be
recruited to lesions via MCP-1 and CCR2 or SAA and FPR2.
Previous studies have investigated the role of SAA in lesion
formation in ApoE/ mice. Dong et al found that overex-
pression of SAA1 in hepatocytes via recombinant lentiviral
infection in male ApoE/ mice resulted in an increase in
lesional area in the aortic root after 14 weeks on a chow diet;
however, no difference was found in lesion size after
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12 weeks on a high-fat diet (16% fat, 0.25% cholesterol).11 De
Beer et al demonstrated recently that the absence of SAA1
and SAA2 in ApoE/ mice did not affect lesion formation in
the whole aorta or the aortic root in male and female mice fed
a chow diet for 50 weeks or a WTD for 12 weeks.9 Although
this may seem to contradict our results, it should be noted
that the lesions in the Saa/ApoE/ mice were signifi-
cantly larger and more advanced than we observed in the
Ldlr/ mice after 6 weeks on a WTD. In our studies, too, no
difference in lesion size was observed when larger, more
advanced lesions were present. Taken together, these data
support the conclusion that SAA influences early lesion
formation.
Lesion formation was found to be independent of plasma
lipid levels because no difference was found in plasma levels
of total, VLDL, or LDL cholesterol after 6 weeks of a WTD;
however, the absence of SAA seemed to modestly increase
plasma triglycerides and HDL cholesterol after 6 weeks of a
WTD. This finding is surprising because SAA is mostly an HDL-
associated apolipoprotein, and SAA’s dramatic increase
during the acute-phase response is associated with a
significant reduction in HDL and apoA-I.39 Nonetheless, the
SAA levels induced by the WTD feeding were upregulated 4-
fold, whereas during the acute-phase response, SAA levels
were upregulated 100- to 1000-fold compared with a
noninflammatory state. In contrast, after 12 weeks of a
WTD, VLDL and LDL levels were increased and HDL was
decreased in the Saa/Ldlr/ mice. This is a proathero-
genic lipid profile and could have contributed to the accel-
erated lesion growth in the ascending aorta of the Saa/
Ldlr/ mice so that, at this time, there is no difference
between the lesions sizes of the 2 strains.
Using bone marrow chimeras, we also showed that SAA
produced by macrophages was more likely to promote lesion
formation in the ascending aorta and an increase in lesional and
splenic macrophages. These observations are noteworthy,
given that hepatocytes produce the majority of SAA that is
present in the plasma, with macrophages contributing little if
any plasma SAA. These results suggest that SAAmay have local
effects on lesional macrophages prior to or after secretion or
effects on other cells in the vessel wall that may influence lesion
formation. Consistent with the role of macrophage-derived
SAA, the transgenicmediated overexpression of human SAA1 in
adipocytes also does not influence the development of
atherosclerosis in chow-fed ApoE/ mice.12
There is an emerging consensus that monocytosis is a risk
factor for the development of atherosclerosis in a variety of
models and in humans. In most cases, this involves the
elevation of Ly6chi proinflammatory monocytes.33,40 These
monocytes enter the intima, where they differentiate into
macrophages expressing CCR2, the receptor for MCP-1, and
promote lesion development in atherosclerosis-susceptible
sites.31,41 We reported a decrease in atherosclerosis despite
an increase in total monocytes in the blood of Saa/ Ldlr/
mice. In this case, the monocytes were predominantly Ly6clo
monocytes that are thought to patrol the vascular endothe-
lium.38 Ly6clo monocytes do not express CCR2 and generally
are thought to develop into alternatively activated and
antiatherogenic M2 macrophages that have been suggested
to promote tissue remodeling and the resolution of athero-
genesis.42 Consequently, this increment of Ly6clo polarized
monocytes should not be taken to contradict the emerging
consensus. The increase in Ly6clo monocytes could well
contribute to the reduced atherosclerosis observed in the
absence of SAA expression. Although a higher level of Ly6clo
monocytes and a reduction of atherosclerosis were both
found in the absence of SAA after 6 weeks of a WTD, no
correlation was found between these 2 observations by
Pearson’s correlation coefficient analysis. It is quite possible
that these 2 phenomena were induced simultaneously by a
hyperlipidemic state but regulated by separate mechanisms.
The way in which SAA influences the polarity of blood
monocytes has yet to be established. We did not observe an
effect of SAA expression on the proliferation of blood
monocytes, as determined by cell cycle analysis (data not
shown), indicating that SAA does not influence monocyte
proliferation. A possibility is that SAA influences expression of
factors involved in monocyte subset differentiation or survival,
such as nuclear orphan receptor NRA41.43
In conclusion, we showed that SAA produced by macro-
phages increased the amount of lesional macrophages,
promoting early lesion development. It is clear from this
study and others that the role of SAA in atherosclerosis is
dependent on several factors including the genetic back-
ground of the different models used for study, lesion site and
size, and the duration of an experiment. Further studies are
needed to further clarify how SAA may influence lesion
development and blood and tissue monocyte and macrophage
homeostasis.
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